Antiretroviral treatment interruption among people living with HIV during COVID-19 outbreak in China: a nationwide cross-sectional study.
Yinghui SunHui LiGanfeng LuoXiaojun MengWei GuoThomas FitzpatrickYunlong AoAnping FengBowen LiangYuewei ZhanAmakobe SandeFeng XieYing WangHan-Zhu QianYong CaiHuachun ZouPublished in: Journal of the International AIDS Society (2020)
A significant proportion of PLHIV in China are at risk of ATI during the COVID-19 outbreak and some have already experienced ATI. Correlates of ATI and self-reported barriers to ART suggest that social disruptions from COVID-19 have contributed to ATI. Our findings demonstrate an urgent need for policies and interventions to maintain access to HIV care during public health emergencies.